Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body  by David, Tirone E. et al.
AORTIC AND MITRAL VALVE REPLACEMENT WITH RECONSTRUCTION OF THE 
INTERVALVULAR FIBROUS BODY 
Tirone E. David, MD 
James Kuo, MD 
Susan Armstrong, MSc 
Objective: The intervalvular fibrous body between the aortic and mitral 
valves can be damaged by infective ndocarditis, degenerative calcification, 
or multiple previous heart valve operations, making double valve replace- 
ment difficult. We have managed this problem by approaching the aortic 
and mitral valves through the aortic root and the dome of the left atrium. 
After excising the aortic valve, the diseased fibrous body, and the mitral 
valve, we suture a properly tailored patch of Dacron fabric or bovine 
pericardium to the lateral and medial fibrous trigones and to the aortic 
root, reestablishing the aortic and mitral anuli. A prosthetic mitral valve is 
implanted and a separate patch is used to close the left atriotomy before 
implantation of a prosthetic aortic valve. This study was undertaken to 
determine the efficacy of this operation. Methods: Forty-three patients 
underwent reconstruction of the intervalvular fibrous body during aortic 
and mitral valve replacement because of infective ndocarditis with abscess 
in 14 patients, extensive calcification in 9, lack of fibrous tissue because of 
multiple previous operations-in 10, and to enlarge the aortic and mitral 
anuli in 10. The group comprised 18 men and 25 women with a mean age 
of 58 -+ 12 years. Thirty-two patients had had one or more previous heart 
valve replacements. All patients were in New York Heart Association 
functional classes II I  and IV, and 9 patients were in shock before the 
operation. Results: Seven operative deaths occurred (16%). Early prosthetic 
valve endocarditis developed in two patients and necessitated reoperation. 
Follow-up extended from 4 to 108 months, with a mean of 38 months. No 
patient was lost to follow-up. Six late deaths occurred. The actuarial 
survival a! 6 years was 56% _ 6%. A Doppler echocardiographic study 
revealed normal prosthetic valve function and anatomically intact anuli in 
all 30 long-term survivors. Conclusions: Reconstruction of the intervalvular 
fibrous body during aortic and mitral valve replacement is a satisfactory 
operative approach in patients with complex valve annular pathology. 
(J Thorac Cardiovasc Surg 1997;114:766-72) 
T he aortic and mitral valves are connected by a fibrous body that extends from the lateral to the 
medial fibrous trigones. This fibrous structure is 
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seldom more than 1 cm in height, and from the 
ventricular side it is indistinguishable from the an- 
terior leaflet of the mitral valve until the point where 
the noncoronary cusp of the aortic valve begins. 
From the atrial side, the dome of the left atrium is 
attached to it, separating the anterior leaflet of the 
mitral valve from the aortic root. This fibrous body 
may be damaged by infective endocarditis, degener- 
ative calcification, or previous mitral valve replace- 
ment, making combined aortic and mitral valve 
replacement difficult. 1-s 
Patients with rheumatic heart valve disease may 
have small aortic and mitral anuli partially as a 
consequence of inadequate growth or fibrotic con- 
traction of the fibrous body. Double valve replace- 
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ment in these patients is often complicated by 
patient-valve size mismatch. 9'10 
This article describes our experience with aortic 
and mitral valve replacement in patients who 
needed reconstruction of the intervalvular fibrous 
body. 
Patients and methods 
From 1985 to 1996, 43 patients who needed aortic and 
mitral valve surgery were found to have a diseased inter- 
valvular fibrous body. Table I shows the clinical profile of 
these patients. The principal indication for operation was 
infective ndocarditis n 14 patients (native valve in 3 and 
prosthetic valve in 11) and symptoms of congestive heart 
failure in 29. The offending microorganisms in patients 
with active infective endocarditis were staphylococci in 6 
patients, streptococci in 5, and other bacteria in 3. The 
indication for reconstruction of the intervalvular fibrous 
body was abscess in 14 patients, extensive calcification of 
the mitral anulus and fibrous body in 9, lack of tissue to 
secure the prosthetic valves because of previous valve 
replacements in 10, and small aortic and mitral anuli in 10. 
Eleven patients had more than one of the aforementioned 
indications. 
Operative procedures. An oblique aortotomy was per- 
formed and the aortic valve was excised. The aortotomy 
was then extended into the noncoronary aortic sinus and 
aortic anulus until it reached the dome of the left atrium, 
which was incised cephalad from the aortic root to the 
level of the right pulmonary artery, as illustrated in Fig. 1. 
The left atrium was exposed, and the mitral valve and the 
diseased intervalvular fibrous body were excised. The 
extensiveness of this resection varied with the pathologic 
process in the fibrous body. It ranged from an en bloc 
resection including the dome of the left atrium, the fibrous 
body, and the mitral valve in patients with a large abscess 
in this area, to a simple incision in the central portion of 
the fibrous body in patients who had elective double valve 
replacement and were found to have small aortic and 
mitral anuli. The fibrous body was reconstructed with a 
triangular patch of glutaraldehyde-fixed bovine pericar- 
dium in patients who had endocarditis and Dacron fabric 
in the others, as shown in Fig. 2. The sides of the patch 
were sutured to the lateral and medial fibrous trigones 
and aortic root with a continuous 3-0 polypropylene 
suture. A prosthetic mitral valve was secured to the mitral 
anulus posteriorly and to the pericardial patch superiorly. 
Before the prosthetic mitral valve was implanted, a second 
triangular patch was placed on the outside of the first 
patch and used to close the left atriotomy, as illustrated in 
Fig. 3. A prosthetic aortic valve was secured to the aortic 
anulus and to the pericardial patch, as demonstrated in 
Fig. 4. The patch was used to close the right side of the 
aortotomy. This operation was performed in 33 patients. 
The posterior mitral anulus was either heavily calcified 
or destroyed by endocarditis n 10 patients. In addition to 
excision of the fibrous body, the posterior fibrous mitral 
anulus was also debrided in these patients. The entire base 
of the left ventricle was reconstructed with a single large 
patch of glutaraldehyde-fixed bovine pericardium, as illus- 
Table I. Clinical profile 
No. of patients 43 
Age (yr) 
Mean +- SD (range) 58 _+ 12 (31-80) 
Sex 
Male 18 (42%) 
Female 25 (58%) 
ECG 
Sinus 31 (72%) 
Atrial fibrillation 10 (23%) 
Heart block 2 (5%) 
NYHA functional class 
III 10 (23%) 
IV 33 (77%) 
Preoperative shock 9 (21%) 
Previous MVR + AVR 32 (74%) 
Active infective ndocarditis 14 (33%) 
LV ejection fraction 
>55% 11 (25%) 
41%-54% 27 (63%) 
21%-40% 5 (12%) 
Tricuspid insufficiency 15 (35%) 
Coronary artery disease 3 (7%) 
Timing of operation 
Elective 16 (37%) 
Urgent 18 (42%) 
Emergency 9 (21%) 
SD, Standard eviation; ECG, electrocardiogram; NYHA, New York Heart 
Association; MVR, mitral valve replacement; AVR, aortic valve replace- 
ment; LV,, left ventricular. 
trated in Fig. 5. The patch was sutured to the endocar- 
dium of the left ventricle posteriorly, to the lateral and 
medial fibrous trigones, and to the aortic root. 
Table II summarizes the operative data. 
Results 
Seven operative deaths occurred (16%), 2 caused 
by technical problems, 2 by myocardial infarction, 2 
by multiorgan failure, and 1 by hemorrhagic stroke. 
Three of 14 patients with infective endocarditis died, 
and 5 of 9 patients in preoperative shock died. 
Postoperative complications included reexploration 
of the mediastinum for bleeding in 3 patients, 
insertion of a permanent transvenous pacemaker for 
heart block in 6, and early prosthetic valve endocar- 
ditis in 2 patients who did not have endocarditis 
before the operation. In both patients the patches 
and valves were successfully changed. 
Operative survivors have been followed up from 4 
to 108 months (mean 38 _+ 29 months). No patient 
was lost to follow-up. Six late deaths have occurred, 
caused by cerebral bleeding in 1, late prosthetic 
valve endocarditis in 1 (patient refused reopera- 
tion), congestive heart failure in 2, and noncardiac 
causes in 2. The actuarial survival is shown in F ig  6; 
it was: 56% +_ 6% a~: 6 years. 
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Fig. 1. An oblique aortotomy is extended into the mitral anulus and dome of the left atrium. The aortic 
and mitral valves are excised. 
Fig. 2. A properly tailored patch is used to reconstruct the intervalvular fibrous body. 
Thirty patients were alive at the last follow-up 
contact, and only 2 had symptoms attributable to 
their heart disease. The remaining 28 (93%) had 
no symptoms referable to cardiac disease. Every 
patient had a Doppler echocardiographic study 
and no patient had prosthetic valve dysfunction 
or prosthetic valve dehiscence. No echocardio- 
graphic or radiographic evidence of calcification 
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Fig. 3. A mitral valve prosthesis i  secured to the mitral 
anulus posteriorly and to the patch superiorly. A separate 
patch is used to close the left atriotomy. 
Fig. 4. An aortic valve prosthesis is secured to the aortic 
anulus and patch. The patch is used to close the right side 
of the aortotomy. 
was detected in any of the bovine pericardial 
patches. 
Discussion 
The surgical disease described in this study is 
uncommon. At the Toronto Hospital, where approx- 
imately 650 patients with heart valve disease are 
operated on annually, only 3 to 5 patients with aortic 
and mitral valve disease are found to have a dam- 
aged intervalvular fibrous body. The most common 
cause of damaged intervalvular fibrous body is in- 
fective endocarditis of the aortic and mitral valve 
with paravalvular bscess. 1'2 Only a few reports on 
the surgical treatment ofabscess of the intervalvular 
fibrous body have been published. 3-5 In the present 
study, 14 patients had endocarditis of the aortic and 
mitral valve with an abscess in the intervalvular 
fibrous body. Eleven of 14 patients had prosthetic 
valve endocarditis. The radical resection of the 
abscess and reconstruction f the base of the heart 
with glutaraldehyde-fixed bovine pericardium and 
valve replacement cured the infection, and 11 oper- 
ative survivors had normally functioning prosthetic 
valves during the years of follow-up. 
Another uncommon pathologic process that 
makes mitral valve surgery difficult and hazardous i
the so-called "horseshoe" calcification of the mitral 
anulus, which occasionally extends into the fibrous 
trigones and intervalvular fibrous body. 6' 7 Although 
mitral valve repair is feasible in some of these 
patients,Y, 8 when the calcification extends into the 
Table II. Operative data 
Reconstruction of fibrous body 33 (77%) 
Reconstruction of fibrous body + MA 10 (23%) 
Patch material 
Bovine pericardium 28 (65%) 
Dacron fabric 15 (35%) 
AVR + MVR 
Mechanical valves 30 (70%) 
Bioprosthetic valves 13 (30%) 
Associated procedures 
TV annuloplasty 15 (35%) 
PV replacement 1 (2%) 
Coronary artery bypass 3 (7%) 
Aortic root replacement 1 (2%) 
Crossclamp time (min) 121 _+ 22 
Mean ± SD 
Cardiopulmonary b pass time (min) 145 ± 28 
Mean ± SD 
MA, Mitral anulus; AVR, aortic valve replacement; MVR, mitral valve 
replacement; TV, tricuspid valve; PV, pulmonary valve; SD, standard 
deviation. 
fibrous trigones and aortic valve, combined aortic 
and mitral valve replacement is usually necessary. 
Of 9 patients with this disease, 6of them had already 
had at least one previous mitral valve replacement 
elsewhere and were referred because of prosthetic 
mitral valve dehiscence. The calcium had not been 
removed in any of these 6 patients at the previous 
operations. We managed these patients by excising 
all calcified tissues and reconstructing the entire 
base of the left ventricle with bovine pericardium. 
One of these 9 patients required reoperation for 
early prosthetic valve endocarditis. He had had 4 
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Fig. 5. Technique used to reconstruct the entire mitral anulus and the intervalvular fibrous body. 
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mitral valve replacements elsewhere and the recon- 
struction of the base of the heart had been his fifth 
heart operation. The postoperative course after the 
sixth operation was stormy, but he survived and 
eventually did very well. The remaining 8 patients 
had uneventful postoperative courses and had nor- 
mally functioning prosthetic valves at the most re- 
cent examination. 
Reoperations for failed prosthetic heart valves 
are usually associated with increased operative mor- 
tality and morbidity because of advanced symptoms 
or complex anatomic factors, or both. One of these 
anatomic factors is a damaged valve anulus. This 
problem is often seen after multiple previous valve 
replacements or when the prosthetic valves have 
been in place for a long time, usually one or two 
decades. The intervalvular fibrous body becomes 
rigid and sometimes calcified, and it fractures as the 
valve sutures are placed or tied down. Although it is 
possible to secure the aortic valve prosthesis n the 
sewing ring of the mitral valve prosthesis in that 
area, we do not believe this should be done when 
mechanical valves are used. Inadequate intervalvu- 
lar fibrous body was the indication for reconstruc- 
tion in 10 patients in our series. Two of these 
patients died; both were in cardiogenic shock before 
the operation because of thrombosed mechanical 
valves. 
Prosthetic valve-patient mismatch as been doc- 
umented after aortic valve replacement. 9' 10 It has 
been suggested by Dusmenil and associates 11 that 
the indexed prosthetic aortic valve area should not 
be less than 0.9 cm2/m 2. This type of information is
not available for mitral valve replacement, but we 
estimate that the indexed prosthetic mitral valve 
area should be 1.3 to 1.5 cm2/m 2. Smaller prosthetic 
mitral valves are usually associated with symptoms 
of pulmonary congestion during exercise. 
In 1979 Manouguian, Abu-Aishah, and Neitze112 
described an experimental procedure whereby both 
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the aortic and mitral anuli were enlarged by increas- 
ing the width of the intervalvular fibrous body. In a 
report on patch enlargement of the aortic anulus in 
8 patients, Manouguian and Seybold-Epting 13 de- 
scribed the case of 1 patient who had severe mitral 
regurgitation after aortic valve replacement with 
enlargement of the aortic anulus and required mi- 
tral valve replacement 4 days later. Because the 
fibrous body had been divided at the initial opera- 
tion, a Dacron patch was used to close the gap and 
to enlarge both the mitral and aortic anuli. We have 
performed this procedure in 10 patients who re- 
quired aortic and mitral valve replacement and were 
found to have small anuli. All patients had rheu- 
matic heart disease; 5 had had previous valve sur- 
gery and had prosthesis-patient mismatch; no pa- 
tient had an aortic anulus larger than 19 mm, and 3 
patients had a mitral anulus of 23 mm or less. After 
reconstruction of the intervalvular fibrous body, the 
prosthetic mitral valve implanted was 27 or 29 mm 
in all patients and the prosthetic aortic valve was 21, 
23, or 25 ram, depending on the patient's body 
surface area, to prevent prosthesis-patient mis- 
match. Two patients died after the operation; oper- 
ative survivors have had normally functioning pros- 
thetic valves and adequate ffective valve areas. 
Combined aortic and mitral valve replacement 
with reconstruction f the intervalvular fibrous body 
is a long operation, particularly in patients who have 
had multiple previous heart valve operations. Long 
operations are associated with an increased risk of 
intraoperative contamination and perioperative bac- 
teremia. Early prosthetic valve endocarditis devel- 
oped in two of our patients. We ordinarily give 
prophylactic antibiotics for 24 hours after cardiac 
operations, but because of this study we changed our 
policy and will give intravenous antibiotics for at 
least 2 days in patients who undergo complex and 
long cardiac valve operations. 
The approach used to treat this small number of 
patients with aortic and mitral valve disease and 
complex annular abnormalities was associated with 
high mortality and morbidity, but we believe that 
most of these patients would not survive conven- 
tional heart valve replacement. 
Although we have concerns about the durability 
of glutaraldehyde-treated bovine pericardium as 
heart valve anuli because it may degenerate and the 
prosthetic valve may dehisce, it has been an excel- 
lent material for use in reconstructing the heart in 
patients with paravalvular abscess and has given very 
satisfactory midterm results. 1' s 
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Discussion 
Dr. Alain F. Carpentier (Paris, France). The authors 
must be congratulated for bringing to our attention a very 
difficult problem for construction of the aortic-mitral 
junction when destroyed by infection or calcification. The 
type of reconstructive operation depended in their series 
on the extension of the lesions~ For lesions limited to the 
aortic-mitral triangle, a simple triangular patch can be 
used. For lesions extending to the aortic and the mitral 
anulus, they used a large single patch of bovine pericar- 
dium in which an opening is made through which to place 
and secure a mitral valve prosthesis. 
The first of these techniques i  known and widely used 
by most surgeons with good results. The second, however, 
is a significant improvement over a similar technique 
described some 10 years ago, in which a large oval patch 
was sutured to the left atrial wall in the supraannular 
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position. The technique proposed by these authors has a 
lower incidence of patch and valve dehiscence. 
The most  important difference is the fact that the 
authors propose to secure the patch to the left ventricle 
itself. This approach allows the surgeon to use a smaller 
patch and to secure the patch in a stronger area; therefore 
the risk of displacement of the mitral prosthesis and 
dehiscence of the patch is reduced. 
It is probably appropriate to mention another alterna- 
tive that I prefer to use in this difficult situation, which is 
used often in a homograft aortic Valve with the mitral 
leaflet left attached to the aortic homograft. This anterior 
leaflet is used to reconstruct the junction, and then the 
mitral valve anulus is reconstructed with a sliding plastic 
repair Of the left atrium secured to the upper limit of the 
ventricle. 
I have three questions for Dr. Kuo. First, is your patch 
reinforced with a layer of Dacron fabric? Second, how do 
you minimize the motion of the mitral valve between 
systole and diastole to reduce the incidence of dehiscence, 
patch dehiscence or valve dehiscence? Third, why do you 
not use the homograft valve more often and use the mitral 
valve as a living tissue, particularly in patients with 
bacterial endocarditis? 
Dr. Ratna A. Magotra (Bombay, India). I would like to 
share the sentiments regarding some patients with rheu- 
matic heart disease with mitral stenosis, aortic stenosis, 
and gross left ventricular hypertrophy. 
In our experience, ven after double valve replacement, 
it was not infrequent to have less than satisfactory egres- 
sion of the left ventricle. These patients continued to have 
symptoms, with normally functioning prosthetic heart 
valves but very high transvalvuiar gradients. 
The technique described by the authors has been 
successfully used to enlarge the mitral and aortic anuli so 
that larger prosthetic valves can be implanted. 
My only question for Dr. Kuo concerns heart block. He 
describes ix patients requiring permanent pacemakers, 
and I presume they include the two patients who had 
permanent heart block before the operation. Were there 
any instances of temporary heart block and, if so, how long 
did it last? 
Dr. Kuo. I would like to thank Professor Carpentier for 
his kind remarks. In answer to his first question, we did 
not use Dacron fabric for reinforcement. 
Regarding his second question, the rocking motion of 
the mitral valve during systole and diastole does worry us 
a bit. Dr. David modified his technique to try to reduce 
this rocking motion by not leaving too much patch be- 
tween the sewing ring and the newly reconstructed mitral 
anulus. Obviously this is a worry, but we have not had any 
periprosthetic leak as a result of that in the 30 patients 
who survived the operation. 
Third, we have not actually used a homograft in this 
situation. 
Regarding Dr. Magotra's question, I suspect hat the 
poor regression of the left ventricular hypertrophy in 
her group of patients may be the result of patient-valve 
size mismatch. If too small a valve is Used, the left 
ventricular hypertrophy does not regress as much, as is 
shown very nicely in patients who previously had stent- 
less valves. 
The six patients who had pacemakers all had complete 
heart block after the operation. That did not include the 
two patients with complete heart block who had a pace- 
maker in place before the operation. 
